Phototransformations of sensitizers. 1. Significance of the nature of the sensitizer in the photobleaching process and photoproduct formation in aqueous solution

Journal of Photochemistry and Photobiology B: Biology

Volumn 39, Issue 2, 1997, Pages 167-171

  Rotomskis, R ^a   Streckyte, G ^a   Bagdonas, S ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Absorption spectroscopy; Photobleaching; Photodynamic dose; Photoproducts; Photosensitized tumour therapy; Porphyrins

Indexed keywords

HEMATOPORPHYRIN; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN II; PHOTOSENSITIZING AGENT; TALAPORFIN; TETRAKIS(4 SULFOPHENYL)PORPHINE; TETRASULFOPHTHALOCYANINE ALUMINUM;

AQUEOUS SOLUTION; ARTICLE; BLEACHING; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSFORMATION; LIGHT ABSORPTION; PHOTOACTIVATION; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 0031171616     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)00015-2     Document Type: Article

References (24)

1. [1] J. Moan, T. Christensen, P.B. Jacobsen, Porphyrin-sensitized photoinactivation of cells in vitro, in: D.R. Doiron, C.J. Corner (Eds.), Porphyrin Localization and Treatment of Tumours, Alan R. Liss, New York, 1984, pp. 419-442.
2. [2] J. Moan, Effect of bleaching of porphyrin sensitizers during photodynamic therapy, Cancer Lett. 33 (1986) 45-53.
3. [3] J. Moan, A change in the quantum yield of photoinactivation of cells observed during photodynamic treatment, Lasers Med. Sci. 3 (1988) 93-97.
4. [4] J. Moan, D. Kessel, Photoproducts formed from Photofrin II in cells, J. Photochem. Photobiol. B: Biol. 1 (1988) 429-436.
5. [5] J. Rotomskiene, R. Kapociute, R. Rotomskis, G. Jonusauskas, T. Szito, A. Nizhnik, Light-induced transformations of hematoporphyrin diacetate and hematoporphyrin, J. Photochem. Photobiol. B: Biol. 2 (1988) 373-379.
6. [6] S. Kinoshita, T. Seki, T.F. Liu, T. Kushida, Fluorescence of hematoporphyrin in living cells and in solution, J. Photochem. Photobiol. B: Biol. 2 (1988) 195-208.
7. [7] K. Konig, W. Dietel, Lazerinduzierte Tumor-Fluoreszediagnostik am Beispiel des Soliden Ehrlichcarcinoms, Arch. Geschwulstforsch. 60 (1990) 1-9.
8. [8] K. Konig, H. Wabnitz, W. Dietel, Variation in the fluorescence decay properties of hematoporphyrin derivative during its conversion to photoproducts, J. Photochem. Photobiol. B: Biol. 8 (1988) 103-111.
9. [9] A. Ruck, C. Hildebrandt, T. Kollner, H. Schneckenburger, R. Steiner, Competition between photobleaching and fluorescence increase of photosensitizing porphyrins and tetrasulphonated chloroaluminiumphthalocyanine, J. Photochem. Photobiol. B: Biol. 5 (1990) 311-319.
10. [10] G. Streckyte, R. Rotomskis, Phototransformation of porphyrins in aqueous and micellar media, J. Photochem. Photobiol. B: Biol. 18 (1993) 259-263.
11. [11] R. Rotomskis, V. Vaicaitis, A. Piskarskas, Time-resolved absorbance spectroscopy of hematoporphyrin and its photoproducts, Chem. Phys. Lett. 202 (1993) 233-236.
12. [12] K. Konig, H. Schneckenburger, A. Ruck, R. Steiner, In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins, J. Photochem. Photobiol. B: Biol. 18 (1993) 287-290.
13. 6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors, Photochem. Photobiol. 58 (1993) 346-350.
14. [14] T.S. Mang, T.J. Dougherty, W.R. Potter, D.G. Boyle, S. Sommer, J. Moan, Photobleaching of porphyrins used in photodynamic therapy and implications for therapy, Photochem. Photobiol. 45 (1987) 501-506.
15. [15] D.G. Boyle, W.R. Potter, Photobleaching of Photofrin II as a means of eliminating skin photosensitivity, Photochem. Photobiol. 46 (1987) 997-1001.
16. [16] W.R. Potter, T.S. Mang, T.J. Dougherty, The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitiser, Photochem. Photobiol. 46 (1987) 96-101.
17. [17] J.D. Spikes, Quantum yields and kinetics of the photobleaching of hematoporphyrin, photofrin II, tetra(4-sulfonatophenyl)-porphin and uroporphyrin, Photochem. Photobiol. 55 (1992) 797-808.
18. [18] H.H. Inhoffen, H. Brockmann Jr., K.M. Bliesener, Photo-protoporphyrin und ihre umwandlung in spirographis-sowie isospirographis-porphyrin, Liebigs Ann. Chem. 730 (1969) 173-185.
19. [19] G.S. Cox, D.G. Whitten, Mechanisms for the photooxidation of Protoporphyrin IX in solution, J. Am. Chem. Soc. 104 (1982) 516-521.
20. [20] E.F. Gudgin Dickson, R.H. Pottier, On the role of protoporphyrin IX photoproducts in photodynamic therapy, J. Photochem. Photobiol. B: Biol. 29 (1995) 91-93.
21. [21] R. Rotomskis, G. Streckyte, J. Didziapetriene, Steady state and time-resolved absorption spectroscopy of porphyrins aggregates: relation to photosensitized tumour therapy, in: P.A. Apanasievich, N.I. Koroteev, S.G. Kruglik, V.N. Zadkov (Eds.), 5th International Conference on Laser Application in Life Sciences, Proc. SPIE 2370 (1995) 73-84.
22. [22] G. Streckyte, R. Rotomskis, Phototransformations of porphyrins under clinically relevant light irradiation, Biology 3 (1993) 26-31.
23. [23] T.J. Dougherty, W.R. Potter, K.R. Weinshaupt, The structure of the active component of hematoporphyrin derivative, in: A. Andreoni, R. Cubeddu (Eds.), Porphyrins in Tumour Phototherapy, Plenum, New York, 1984, pp. 23-35.
24. [24] L. Giniunas, R. Rotomskis, V. Smilgevicius, A. Piskarskas, J. Didziapetriene, L. Bloznelyte, L. Griciute, Activity of haematoporphyrin derivative photoproduct in photodynamic therapy in vivo, Lasers Med. Sci. 6 (1991) 425-428.